News Channel Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Channel Asia.

Press releases published on September 9, 2026

Sep. 9, 2026

Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada

Indeterminate GlobeNewswire

Sep. 9, 2026

XCharge Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Sep. 9, 2026

Bilibili Inc. Announces Completion of US$500 Million Marketed Convertible Senior Notes Offering, Concurrent Equity Placement and Concurrent Delta Repurchase

Indeterminate GlobeNewswire

Sep. 9, 2026

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

Sep. 9, 2026

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

Sep. 9, 2026

GHD selected to deliver upgrades at Skyway wastewater treatment plant in Ontario

Indeterminate GlobeNewswire

Sep. 9, 2026

Koryx Copper Announces Further Drill Results at the Haib Copper Project in Southern Namibia

Indeterminate GlobeNewswire

Sep. 9, 2026

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

Sep. 9, 2026

Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib

Indeterminate GlobeNewswire

Sep. 9, 2026

Erdene Enters Into Automatic Securities Purchase Plan

Indeterminate GlobeNewswire

Sep. 9, 2026

INLIF LIMITED Announces Adjournment of Extraordinary General Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

MapLight Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Indeterminate GlobeNewswire

Sep. 9, 2026

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

Aya Gold & Silver Announces Updated PEA for Boumadine: After-Tax NPV Doubles to $3.5B with 93% IRR

Indeterminate GlobeNewswire

Sep. 9, 2026

OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Digital Substations Market Size, Share, Insights, Competitive Intelligence, Demand

Indeterminate GlobeNewswire

Sep. 9, 2026

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Azimut Accelerates District-Scale Gold Exploration at Wabamisk

Indeterminate GlobeNewswire

Sep. 9, 2026

Azimut accélère l’exploration sur Wabamisk

Indeterminate GlobeNewswire